Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
504 questions in 57 reviews · Kidney and Transplant
current versionsNo studies 504 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Higher blood flow vs standard blood flow Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Long (> 20 cm) vs short (≤ 20 cm) catheter Recovery of kidney function · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Polyethylenimine‐treated membrane (AN69ST) vs other membranes Death from any cause at day 28 of · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Polyethylenimine‐treated membrane (AN69ST) vs other membranes Recovery of kidney function · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Polyethylenimine‐treated membrane (AN69ST) vs other membranes Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Flat plate vs hollow fibre filter of the same membrane type Death from any cause at day 28 of · people with AKI receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Flat plate vs hollow fibre filter of the same membrane type Recovery of kidney function · people with AKI receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Flat plate vs hollow fibre filter of the same membrane type Vascular access complications · people with AKI receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
More and shorter vs standard hollow fibre filter of the same membrane type Death from any cause at day 28 of · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
More and shorter vs standard hollow fibre filter of the same membrane type Recovery of kidney function · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
More and shorter vs standard hollow fibre filter of the same membrane type Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
CVVHD vs CVVH or CVVHDF Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
CVVHDF vs CVVH Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Raloxifene vs placebo Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 5 and 5D Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Raloxifene vs placebo Mean change in BMD of the total hip · postmenopausal women with osteoporosis and CKD stages 5 and 5D Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Raloxifene vs placebo Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 5 and 5D Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Raloxifene vs placebo QoL · postmenopausal women with osteoporosis and CKD stages 5 and 5D Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Any anti‐osteoporotic drugs vs placebo Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 3‐4 Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Any anti‐osteoporotic drugs vs placebo QoL · postmenopausal women with osteoporosis and CKD stages 3‐4 Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Mycophenolate mofetil vs levamisole Relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Mycophenolate mofetil vs cyclosporin Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Levamisole vs steroids or placebo or both, or no treatment Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Levamisole vs cyclophosphamide Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Levamisole vs cyclophosphamide Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Rituximab vs placebo or control Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Cyclosporin plus prednisolone vs prednisolone alone Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Cyclosporin plus prednisolone vs prednisolone alone Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Alkylating agents vs cyclosporin Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Alkylating agents vs cyclosporin Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Rituximab vs placebo or control Relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Alkylating agents vs steroids, placebo or both Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Alkylating agents vs steroids, placebo or both Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Intravenous vs oral cyclophosphamide Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Cyclophosphamide vs chlorambucil Frequent relapses · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Cyclophosphamide vs chlorambucil Mean relapse rate/patient/month · SSNS in children Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Rituximab vs cyclophosphamide Kidney function · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Rituximab vs cyclophosphamide Dialysis · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Mycophenolate mofetil vs cyclophosphamide Kidney function · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Kidney function · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Dialysis · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Serious infection · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Azathioprine vs cyclophosphamide Kidney function · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Azathioprine vs methotrexate Kidney function · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Azathioprine vs methotrexate Dialysis · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Relapse · adults with renal vasculitis Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo Kidney function · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo Dialysis · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo Relapse · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Leflunomide vs methotrexate Death · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |
Leflunomide vs methotrexate Kidney function · adults with renal vasculitis for maintenance therapy Interventions for renal vasculitis in adults (2020) · Cochrane | no estimate extracted | NR | No studies |